HAL
50
2
UNM
65
-7
MCHP
47
-8
CMI
71
2
INTU
60
-3
LLY
71
3
ADT
50
2
CCI
36
2
CAG
41
-5
MAT
50
-5
LRCX
62
6
APA
53
5
HRL
23
-12
TXN
50
2
FITB
75
2
GS
76
6
NWSA
64
-15
WHR
50
-5
DUK
52
-5
RSG
47
2
HAL
50
2
UNM
65
-7
MCHP
47
-8
CMI
71
2
INTU
60
-3
LLY
71
3
ADT
50
2
CCI
36
2
CAG
41
-5
MAT
50
-5
LRCX
62
6
APA
53
5
HRL
23
-12
TXN
50
2
FITB
75
2
GS
76
6
NWSA
64
-15
WHR
50
-5
DUK
52
-5
RSG
47
2
Financhill
Back

Vanguard Intermediate-Term Corp Bond Idx Fund ETF Vs. CRISPR Therapeutics AG Industry Stock Comparison

Sell
42

VCIT
Vanguard Intermediate-Term Corp Bond Idx Fund ETF

Last Price:
$83.64
Seasonality Move:
-0.39%
Sell
43

CRSP
CRISPR Therapeutics AG

Last Price:
$55.85
Seasonality Move:
14.46%
Sell
42
Vanguard Intermediate-Term Corp Bond Idx Fund ETF (VCIT) is a Sell

Is Vanguard Intermediate-Term Corp Bond Idx Fund ETF a Buy, Sell or Hold?

  • The current Vanguard Intermediate-Term Corp Bond Idx Fund ETF [VCIT] share price is $83.64. The Score for VCIT is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
  • VCIT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
43
CRISPR Therapeutics AG (CRSP) is a Sell

Is CRISPR Therapeutics AG a Buy, Sell or Hold?

  • The current CRISPR Therapeutics AG [CRSP] share price is $55.86. The Score for CRSP is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
  • CRSP is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

VCIT Stock Price Chart

What is Vanguard Intermediate-Term Corp Bond Idx Fund ETF's stock price today?

  • The Vanguard Intermediate-Term Corp Bond Idx Fund ETF share price today is $83.64
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and VCIT is experiencing selling pressure, which indicates risk of future bearish movement.

CRSP Stock Price Chart

What is CRISPR Therapeutics AG's stock price today?

  • The CRISPR Therapeutics AG share price today is $55.86
    The current trend is relatively stagnant and CRSP is experiencing slight buying pressure.

VCIT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 15.74 Buy
Relative Strength Index (14 RSI): 42.6 Sell
Chaikin Money Flow: -5608064 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (83.64 - 84.22) Sell
Bollinger Bands (100): (83.31 - 84.37) Sell

CRSP Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.28 Sell
Relative Strength Index (14 RSI): 49.16 Sell
Chaikin Money Flow: 78181 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (51.94 - 57.06) Buy
Bollinger Bands (100): (52.44 - 65.4) Sell

VCIT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 83.84 Sell
20-day SMA: 84.01 Sell
50-day SMA: 84.07 Sell
200-day SMA: 82.66 Buy
8-day EMA: 44.34 Buy
20-day EMA: 21.72 Buy
50-day EMA: 9.47 Buy
200-day EMA: 2.48 Buy

CRSP Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 56.25 Sell
20-day SMA: 55.05 Buy
50-day SMA: 58.96 Sell
200-day SMA: 51.1 Buy
8-day EMA: 55.79 Buy
20-day EMA: 55.79 Buy
50-day EMA: 56.36 Sell
200-day EMA: 37.56 Buy

Vanguard Intermediate-Term Corp Bond Idx Fund ETF Earnings Growth & VCIT Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

CRISPR Therapeutics AG Earnings Growth & CRSP Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.26 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.09 per share, and an increase next year of $1.74 per share.

Vanguard Intermediate-Term Corp Bond Idx Fund ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

CRISPR Therapeutics AG Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):